Ensure genome sequencing, boost scrutiny as Covid surges: Centre to states

Amid a fresh global surge in Covid-19 cases, the central government has briefed all states to conduct genome sequencing of samples, the additional chief secretary of Health informed

coronavirus
Photo: Bloomberg
ANI
2 min read Last Updated : Dec 22 2022 | 9:20 AM IST

Amid a fresh global surge in Covid-19 cases, the central government has briefed all states to conduct genome sequencing of samples, the additional chief secretary of Health informed on Wednesday.

Speaking to ANI, Additional Chief Secretary of Health, Manoj Agarwal said the central government briefed all states to ensure proper screening international passengers, as well as genome sequencing, on Tuesday.

"Yesterday (Tuesday), the central government briefed all states on the increasing trend of Covid-19 variants in parts of the world and asked them to ensure that whole genome sequencing is done in all states," he said.

There has been an alarming surge in Covid cases in China, Japan, South Korea, France and the United States.

The spike is being blamed on new Omicron sub-variant BF.7, which has also been detected in four Indian states.

Amid the fresh Covid scare, Union Health Minister Mansukh Mandaviya chaired a high-level meeting to review the prevailing Covid-19 situation in the country and the preparedness of the public health system for surveillance, containment and management of the pandemic.

He urged people to follow Covid-appropriate behaviour and get vaccinated against Covid-19.

Emphasising that the pandemic is not over yet, he asked officials to be fully geared up to challenge and step up surveillance.

In the last six months, India reported four cases of the BF.7 Omicron sub-variant, which is driving the current surge of infections in China.

Sources said there are currently 10 different variants of Covid-19 in the country, with the latest being BF.7.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Coronavirusindian governmentIndiaCoronavirus TestsCoronavirus Vaccine

First Published: Dec 22 2022 | 8:59 AM IST

Next Story